QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) | |
(Address of Principal Executive Offices) |
(Zip Code) |
Title of each class |
Trading Symbol (s) |
Name of each exchange on which registered | ||
Large Accelerated Filer | ☐ | Accelerated Filer | ☐ | |||
Non-Accelerated Filer |
☒ | Smaller Reporting Company | ||||
Emerging Growth Company |
March 31, 2021 |
December 31, 2020 |
|||||||
(Restated) (Unaudited) |
||||||||
Assets |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Cash and securities held in trust account |
||||||||
|
|
|
|
|||||
Total Assets |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Equity |
||||||||
Accounts payable and accrued expenses |
$ | $ | ||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Warrant liability |
||||||||
|
|
|
|
|||||
Total Liabilities |
||||||||
Commitments |
||||||||
Common stock subject to possible redemption, $ |
||||||||
Stockholders’ Equity: |
||||||||
Preferred stock, $ |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total stockholders’ equity |
||||||||
|
|
|
|
|||||
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Equity |
$ | $ | ||||||
|
|
|
|
1 |
Operating expenses |
$ | |||
Business combination expenses |
||||
|
|
|||
Loss from operations |
$ | ( |
) | |
|
|
|||
Other income (expense) |
||||
Interest income |
||||
Change in warrant liability |
( |
) | ||
|
|
|||
Total other expense |
( |
) | ||
|
|
|||
Net loss |
$ | ( |
) | |
|
|
|||
Basic and diluted weighted average redeemable common shares outstanding |
||||
|
|
|||
Basic and diluted net loss per redeemable common share |
$ | ( |
) | |
|
|
|||
Basic and diluted weighted-average non-redeemable common shares outstanding |
||||
|
|
|||
Basic and diluted net loss per non-redeemable common share |
$ | ( |
) | |
|
|
2 |
Common Stock |
Additional Paid-in |
Accumulated |
Total Stockholders’ |
|||||||||||||||||
Shares |
Amount |
Capital |
Deficit |
Equity |
||||||||||||||||
Balance - December 31, 2020 |
$ | $ | $ | ( |
) | $ | ||||||||||||||
Net loss |
— | — | — | ( |
) | ( |
) | |||||||||||||
Balance - March 31, 2021 |
$ | $ | $ | ( |
) | $ | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
3 |
Cash flows from operating activities: |
||||
Net loss |
$ | ( |
) | |
Adjustments to reconcile net loss to net cash used in operating activities: |
||||
Change in warrant liability |
||||
Interest earned on cash and marketable securities held in trust account |
( |
) | ||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
( |
) | ||
Accounts payable and accrued expenses |
||||
|
|
|||
Net cash used in operating activities |
( |
) | ||
|
|
|||
Net change in cash |
( |
) | ||
Cash, beginning of the period |
||||
|
|
|||
Cash, end of period |
$ | |||
|
|
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
Level 1 — | Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. | |
Level 2 — | Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. | |
Level 3 — | Valuations based on inputs that are unobservable and significant to the overall fair value measurement. |
12 |
Fair Value Measured as of March 31, 2021 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets: |
||||||||||||||||
U.S. Money Market held in Trust Account |
$ | $ | $ | $ | ||||||||||||
U.S. Treasury Securities held in Trust Account |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | $ | $ | $ | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
Private stock warrant liabilities |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | $ | $ | $ | |||||||||||||
|
|
|
|
|
|
|
|
Fair Value Measured as of December 31, 2020 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets: |
||||||||||||||||
U.S. Money Market held in Trust Account |
$ | $ | — | $ | — | $ | ||||||||||
U.S. Treasury Securities held in Trust Account |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | $ | — | $ | — | $ | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
Private stock warrant liabilities |
$ | — | $ | — | $ | $ | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | — | $ | — | $ | $ | |||||||||||
|
|
|
|
|
|
|
|
As of December 31, 2020 |
As of March 31, 2021 |
|||||||
Exercise price |
$ | $ | ||||||
Stock price |
||||||||
Volatility |
% | % | ||||||
Probability of completing a business combination |
% | % | ||||||
Term |
||||||||
Risk-free rate |
% | % | ||||||
Dividend yield |
% | % |
Warrant liabilities at December 31, 2020 |
$ | |||
Change in fair value of warrant liabilities |
||||
|
|
|||
Warrant liabilities at March 31, 2021 |
$ | |||
|
|
13 |
14 |
For the Three Months |
||||||||
ended March 31, 2021 |
||||||||
Redeemable |
Non-redeemable |
|||||||
Basic and diluted net loss per share: |
||||||||
Numerator: |
||||||||
Allocation of net loss |
$ | ( |
) | $ | ( |
) | ||
Denominator: |
||||||||
Basic and diluted weighted average shares outstanding |
||||||||
|
|
|
|
|||||
Basic and diluted net loss per share |
$ |
( |
) |
$ |
( |
) | ||
|
|
|
|
15 |
As Previously Reported |
Adjustment |
As Restated |
||||||||||
Balance - December 31, 2020 (Restated) |
$ |
$ |
( |
) |
$ |
|||||||
Net loss (Restated) |
( |
) | ( |
) | ( |
) | ||||||
Change in value of common stock subject to possible redemption (Restated) |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Balance as of March 31, 2021 |
$ |
$ |
$ |
|||||||||
|
|
|
|
|
|
16 |
For the Period from January 1, 2021 through March 31, 2021 |
||||||||||||
As Previously Reported |
Adjustment |
As Restated |
||||||||||
Supplemental Disclosure of Noncash Financing Activities: |
||||||||||||
Change in value of common stock subject to possible redemption (restated) |
$ | $ | ( |
) | $ |
Earnings Per Share for Common Stock |
||||||||||||
As Previously |
||||||||||||
Reported (1) |
Adjustment |
As Restated |
||||||||||
For the Three Months Ended March 31, 2021 |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Basic and Diluted weighted-average redeemable common shares outstanding |
||||||||||||
Basic and Diluted net loss per redeemable common share |
$ | $ | ( |
) | $ | ( |
) | |||||
Basic and Diluted weighted-average non-redeemable common shares outstanding |
( |
) | ||||||||||
Basic and Diluted net loss per non-redeemable common shares |
$ | ( |
) | $ | $ | ( |
) |
(1) - | The weighted average shares outstanding was calculated based on the two-class method, where the earnings per share was determined based on redeemable and non-redeemable common stock. The Company revised its earnings per share calculation to allocate losses by the weighted average shares of redeemable and non-redeemable common stock outstanding for the respective period. |
17 |
18 |
Carrying Value/Amortized Cost |
Gross Unrealized Gains |
Gross Unrealized losses |
Fair Value as of December 31, 2021 |
|||||||||||||
U.S. Money Market |
$ | $ | — | $ | — | $ | ||||||||||
U.S. Treasury Securities |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | $ | $ | ( |
) | $ | |||||||||||
|
|
|
|
|
|
|
|
Carrying Value/Amortized Cost |
Gross Unrealized Gains |
Gross Unrealized losses |
Fair Value as of March 31, 2021 |
|||||||||||||
U.S. Money Market |
$ | $ | $ | $ | ||||||||||||
U.S. Treasury Securities |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | $ | $ | — | $ | ||||||||||||
|
|
|
|
|
|
|
|
19 |
20 |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption; |
• | if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and |
• | if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants. |
21 |
22 |
ITEM 2. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
32 |
Exhibit Number |
Description | |
31.1* | Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934. | |
31.2* | Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934. | |
32.1*(1) | Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
32.2*(1) | Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
101.INS* | XBRL Instance Document | |
101.SCH* | XBRL Taxonomy Extension Schema Document | |
101.CAL* | SXRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB* | XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document |
* | Filed herewith. |
** | Management contract or compensatory plan, contract or arrangement. |
(1) | The certifications on Exhibit 32 hereto are deemed not “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section. Such certifications will not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act. |
33 |
CIPHER MINING INC. | ||||||
Date: January 21, 2022 | By: | /s/ Tyler Page | ||||
Tyler Page | ||||||
Chief Executive Officer | ||||||
(Principal Executive Officer) | ||||||
Date: January 21, 2022 | By: | /s/ Edward Farrell | ||||
Edward Farrell | ||||||
Chief Financial Officer | ||||||
(Principal Financial Officer) |